ID
25303
Beschrijving
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Trefwoorden
Versies (5)
- 31/08/2017 31/08/2017 -
- 31/08/2017 31/08/2017 -
- 04/09/2017 04/09/2017 -
- 04/09/2017 04/09/2017 -
- 11/09/2017 11/09/2017 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
31 de agosto de 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
Similar models
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
C0456984 (UMLS CUI [1,2])
C0456984 (UMLS CUI [1,2])
C0202306 (UMLS CUI [1,2])